Cizzle Biotechnology plc

Cizzle Biotechnology plc is a pioneering medical device company focused on revolutionizing early lung cancer detection. Cizzle Biotechnology is dedicated to improving patient outcomes through innovative diagnostic solutions. The company is developing a cutting-edge blood test designed for the early detection of a majority of different forms of lung cancer.

Based in London, with its primary address at 60 Gracechurch Street, 6th Floor, London, EC3V 0HR, GB, Cizzle Biotechnology leverages advanced research and technology to create accessible and effective diagnostic tools. Cizzle Biotechnology's commitment to innovation positions it as a key player in the medical device industry, striving to make a significant impact on global healthcare.

Cizzle Biotechnology plc is poised for substantial growth and commercial development, aiming to expand its reach and impact in the healthcare sector. We invite the manager of Cizzle Biotechnology to create a customized and exclusive company showcase and product listing on our platform, enhancing visibility and engagement with potential partners and customers.